In written testimony to Congress on March 15, ASCO President Sandra M. Swain, MD, FACP, urged legislators to support a “strong, stable federal investment” in cancer research to continue the progress being made in cancer prevention, detection, diagnosis and treatment.

[Read the rest of this article...]

The first three installments of ASCO’s new payment reform series provide context and background on the growing call for reform of the Medicare physician payment system. Rising healthcare costs, along with misaligned payment formulas, have triggered an unprecedented national dialogue on the need to change the way Medicare reimburses physicians for patient care. Congress, the Administration and the oncology community are seriously examining options for restructuring care delivery and reimbursement to ensure higher-quality and more cost-efficient patient-centered care.

[Read the rest of this article...]

ASCO, patient advocacy groups, and other provider organizations recently sent a letter to Centers for Medicare & Medicaid Services Acting Administrator Marilyn Tavenner urging the agency to correct a longstanding inequity in Medicare coverage for cancer patients wishing to participate in clinical trials.

[Read the rest of this article...]

ASCO recently released a new 12-month overview of 2013 Centers for Medicare and Medicaid Services (CMS) deadlines for new Medicare reporting requ...

[Read the rest of this article...]

The U.S. Food and Drug Administration, out of concern related to a lack of new antibiotic agent approvals, is exploring development of an alternative ...

[Read the rest of this article...]

ASCO has joined others in the oncology community in calling on Congress to reinstate the two percent sequestration cuts to Medicare spending, which will disproportionately reduce payments for critical cancer drugs.

[Read the rest of this article...]

Janssen Products, LP is releasing another lot of DOXIL® (doxorubicin HCl liposome injection) for physicians and their patients, under the regulatory discretion of the U.S. Food and Drug Administration (FDA).

[Read the rest of this article...]

An analysis of self-reported data from outpatient oncology practices that participated in the American Society of Clinical Oncology’s Quality Oncology Practice Initiative (QOPI^®) found a significant increase in performance on quality measures for oncology care over a four-year period, especially in adopting new clinical practices. The study was published on March 11, in the Journal of Clinical Oncology.

[Read the rest of this article...]